Baxter sees Gambro deal neutral to modestly accretive in adjusted FY14 EPS In a company slides presentation Baxter said it sees the Gambro deal neutral to modestly accretive to 2014 adjusted E.P.S. (including estimated amortization of intangible assets); Accretive in 2014 by 20c to 25c per diluted share on a cash basis.
News For BAX From The Last 14 Days
Check below for free stories on BAX the last two weeks.
Piper Jaffray to hold a conference 25th Annual Healthcare Conference is being held in New York on December 3-4 with webcasted company presentations to begin on December 3 at 8 am; not all company presentations may be webcasted. Webcast Link